Funder: American Association for Cancer Research
Due Dates (Anticipated): May 2026 (Letter of Intent) | June 2026 (Full application) | September 2026 (Full application for invited applicants)
Funding Amounts: $350,000 total over three years; covers salary, research expenses, and limited indirect costs.
Summary: Supports independent investigators advancing research on Tumor Treating Fields (TTFields) in cancer, requiring use of the Inovitro® system.
Key Information: All proposals must incorporate the Inovitro® system; AACR membership required at application.